Using a computer algorithm to identify major driver mechanisms in our PTC cohort, the results showed that, in addition to BRAF mutations, NF1, PMS2, CDC27 and PPP4R2 gene mutations are also involved in the development of thyroid cancer, and joint mutations often occur. Here, CDC27 is linked to thyroid gland carcinoma.